Cash Ratio Analysis of Entrada Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointCash Ratio of TRDA
Dec-232.22Good Cash Ratio | Dec-228.59Excellent Cash Ratio | Growth-74.19% |
Cash Ratio Analysis of Entrada Therapeutics Inc
| Cash Ratio of TRDA drastically fell by -74.19 % this year. |
| Cash Ratio with value of 43.32 was highest in Year Dec-21 in last Five Years. |
| Cash Ratio with value of 2.22 was lowest in Year Dec-23 in last Five Years. |
| Latest Cash Ratio with value of 2.22 is lower than Average Cash Ratio of 14.90 in last five years. |
Other Cash Ratio Related Info of TRDA that may interest you.
Entrada Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| TRDA | 15.21 | 15.78 | 3.61 % | Biotechnology |
Defination of Cash Ratio
The Cash Ratio measures the liquidity position of the company. This metric indicates how much the company can cover its current liabilities by its cash and cash equivalents. more ..
Cash Ratio Related Ratios
| CurrentRatio | QuickRatio | DebtToEquityRatio |
Tsr Stability Index
| Good Stability | |
FY - Historical Cash Ratio of Entrada Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
|---|---|---|---|---|---|
| Cash Ratio | 2.22 | 8.59 | 43.32 | 11.62 | 8.77 |
| Change | -74.19 % | -80.17 % | 272.67 % | 32.57 % |
FY Chart of Cash Ratio of Entrada Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)